ARTICLE | Clinical News
Durvalumab: Ph Ib started
December 1, 2016 11:43 AM UTC
OncoPep Inc. (North Andover, Mass.) began an open-label, U.S. Phase Ib trial to compare PVX-410 plus IV durvalumab with or without Revlimid lenalidomide vs. durvalumab alone in about 26 patients. Pati...
BCIQ Company Profiles
BCIQ Target Profiles